Articles

1. E rosette forming lymphoblasts fail to stimulate allogeneic cells in mixed leukocyte culture (MLC)

   • B. G. Leventhal
   • E. Leung
   • D. G. Poplack

   Original Papers Pages: 21 - 25

2. Immunotherapy of cancer

   • Franco M. Muggia

   Short Review Pages: 5 - 9

3. The questionable immunogenicity of certain neoplasms

   • David W. Weiss

   General Review Pages: 11 - 19

4. Interspersion of chemotherapy and active systemic immunotherapy. Experimental and rational bases

   • G. Mathé

   Editorial Pages: 1 - 3

5. Cancer systemic active immunotherapy today — prospects for tomorrow

   • Jordan U. Gutterman

   Editorial Review Pages: 1 - 9

6. The current status of clinical immunotherapy as viewed at the 1976 AACR-ASCO meetings

   • S. K. Carter

   Current Affairs Pages: 275 - 281

7. Trial of BCG immunotherapy in the treatment of resectable squamous cell carcinoma of the bronchus (stages I and II)

   • P. Pouillart
   • G. Mathé
   • R. Parrot

   Short Communication Pages: 271 - 273

8. Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure

   • E. Ribi
   • K. Takayama
   • M. Kelly

   Original Papers Pages: 265 - 270

9. Partial restoration by in vivo thymosin of E-rosettes and delayed-type hypersensitivity reactions in immunodeficient cancer patients

   • L. A. Schaefer
   • J. U. Gutterman
   • A. L. Goldstein

   Original Papers Pages: 259 - 264

10. Immune competence in breast cancer — Relationship of pretreatment immunologic tests to diagnosis and tumor stage

    • P. M. Bolton
    • C. Teasdale
    • L. E. Hughes

    Original Papers Pages: 251 - 258

11. Production of cytotoxic antibody to a benz(a)pyrene-induced sarcoma in mice receiving xenogeneic antitumor immune RNA

    • D. Fritze
    • D. H. Kern
    • Y. H. Pilch

    Original Papers Pages: 245 - 250

12. Immunotherapy of EL4 lymphoma with reovirus

    • G. Mark Kollmorgen
    • Don C. Cox
    • William A. Sansing

    Original Papers Pages: 239 - 244

13. Therapy of spontaneous pulmonary metastases of a murine mammary carcinoma with anaerobic corynebacteria

    • L. Milas
    • K. Mason
    • H. R. Withers

    Original Papers Pages: 233 - 237

14. Nonspecific immunoprevention of L1210 leukemia by cord factor (6-6′ dimycolate of trehalose) administered in a metabolizable oil

    • C. Leclerc
    • A. Lamensans
    • E. Lederer

    Original Papers Pages: 227 - 232

15. Prevention by the MER tubercle bacillus fraction of immunosuppression induced by cancer chemotherapeutic agents

    • Y. Stupp
    • R. Saltoun
    • D. W. Weiss

    Original Papers Pages: 219 - 226

16. Active immunotherapy of L1210 leukemia with neuraminidase-treated, drug-resistant L1210 sublines

    • A. V. LeFever
    • J. J. Killion
    • G. M. Kollmorgen

    Original Papers Pages: 211 - 217

17. Differential effect of asparaginase on lymphocyte subpopulations and alleviation of the immunosuppression by lipopolysaccharide

    • W. C. Gordon
    • W. J. Mandy
    • M. D. Prager

    Original Papers Pages: 205 - 209

18. The current status of immunotherapy for large bowel cancer

    • S. K. Carter

    Short Review Pages: 199 - 203

19. Relevant animal models for tumor immunotherapy

    • R. W. Baldwin

    Editorial Pages: 197 - 198

20. Kinetics of histologic changes in human melanoma after local immunotherapy with BCG

    • A. Khalil
    • H. Rappaport
    • J. L. Misset

    Short Communication Pages: 193 - 196

21. Tumor regression with Q fever rickettsiae and a mycobacterial glycolipid

    • M. T. Kelly
    • D. L. Granger
    • H. G. Stoenner

    Original Articles Pages: 187 - 191

22. Characterization of in vitro reactivity by BCG-treated guinea pigs to syngeneic line-10 hepatocarcinoma

    • I. J. Fidler
    • Marilyn B. Budmen
    • M. G. Hanna Jr.

    Original Articles Pages: 179 - 186

23. The efficacy of BCG-induced tumor immunity in guinea pigs with regional and systemic malignancy

    • M. G. Hanna Jr.
    • Leona C. Peters
    • I. J. Fidler

    Original Articles Pages: 171 - 177

24. Effect of BCG on hematopoietic stem cells: Experimental and clinical study

    • P. Pouillart
    • T. Palangié
    • G. Mathé

    Original Articles Pages: 163 - 169

25. Attempts at non-specific cell-mediated immunorestoration of immunodepressed cancer patients with BCG

    • M. C. Simmler
    • L. Schwarzenberg
    • G. Mathé

    Original Articles Pages: 157 - 161

26. “Active” T-cell Rosettes and total T-rosettes in patients with melanoma following intratumoral inoculation of BCG: A clue to the mechanism of action of bacillus calmette-guérin?

    • J. Wybran
    • L. E. Spitler
    • H. H. Fudenberg

    Original Articles Pages: 153 - 156

27. Intralesional injection of immunostimulants in rat and mouse tumors

    • J-C. Salomon
    • N. Lynch

    Original Articles Pages: 145 - 151

28. Silica abrogation of mycobacterial adjuvant contact suppression of tumor growth in rats and athymic mice

    • D. G. Hopper
    • M. V. Pimm
    • R. W. Baldwin

    Original Articles Pages: 143 - 144

29. BCG vaccination and cancer mortality

    • R. G. Crispen
    • S. R. Rosenthal

    Original Articles Pages: 139 - 142

30. Immunologic approaches to the treatment of human cancer based on a guinea pig model

    • B. Zbar
    • E. Ribi
    • H. J. Rapp

    Short Reviews Pages: 127 - 137

31. Immunodeficiency in cancer patients and immunorestoration

    • M. C. Simmler
    • M. Bruley-Rosset

    Short Reviews Pages: 119 - 126

32. Immunotherapy in the strategy of cancer treatment

    • S. K. Carter

    Editorial Pages: 115 - 118

33. Increase of null cells in patients submitted to long-term active immunotherapy

    • D. Belpomme
    • R. Joseph
    • N. Lelarge

    Letter To CII Pages: 113 - 114

34. BCG in the immunotherapy of Hodgkin's disease and non-Hodgkin's lymphomas

    • B. Hœrni
    • J. Chauvergne
    • C. Lagarde

    Short Communication Pages: 109 - 112

35. Immunotherapy of breast cancer, malignant melanoma, and acute leukemia with BCG: Prolongation of disease free interval and survival

    • J. U. Gutterman
    • G. M. Mavligit
    • E. M. Hersh

    Original Articles Pages: 99 - 107

36. Present status of BCG immunotherapy of malignant melanoma

    • D. L. Morton
    • F. R. Eilber
    • K. P. Ramming

    Original Articles Pages: 93 - 98

37. Various uses of BCG and allogeneic acute leukemia cells to treat patients with acute myelogenous leukemia

    • J. A. Russell
    • B. Chapuis
    • R. L. Powles

    Original Articles Pages: 87 - 91

38. 1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy

    • G. Mathe
    • F. de Vassal
    • C. Jasmin

    Original Articles Pages: 77 - 86

39. Human toxicology of BCG applied in cancer immunotherapy

    • L. Schwarzenberg
    • M. C. Simmler
    • J. L. Pico

    Original Articles Pages: 69 - 76

40. Toxic effects of massive doses of BCG in mice, guinea pigs, and monkeys

    • V. Portelance
    • M. Quevillon
    • Y. Page

    Original Articles Pages: 63 - 67

41. Toxicity studies of intravenously administered BCG in baboons

    • S. Jurczyk-Procyk
    • M. Martin
    • H. Rappaport

    Original Articles Pages: 55 - 61

42. BCG and the specific immune response to tumor

    • I. B. Parr

    Original Articles Pages: 51 - 53

43. The immunoproliferative response of mice to intravenously or subcutaneously injected BCG

    • H. Rappaport
    • A. Khalil

    Original Articles Pages: 45 - 49

44. Enhancement of T suppressor activity in mice by high doses of BCG

    • M. Geffard
    • S. Orbach-Arbouys

    Original Articles Pages: 41 - 43

45. Studies on the mechanisms of action of BCG

    • I. Florentin
    • R. Huchet
    • G. Mathé

    Original Articles Pages: 31 - 39

46. Antitumor activity and other biological properties of two phenotypes isolated from BCG

    • R. Turcotte
    • M. Quevillon

    Original Articles Pages: 25 - 30

47. Comparison of various BCG preparations in the EORTC — ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy

    • O. Halle-Pannenko
    • Ch. Bourut
    • M. Kamel

    Original Articles Pages: 17 - 23

48. Preservation of fresh BCG scarification vaccine at 4, −25, and −70° C

    • M. Gheorghiu
    • L. Chambon

    Original Articles Pages: 11 - 16

49. Experimental basis of BCG systemic immunotherapy

    • I. Florentin

    Short Review Pages: 7 - 9

50. Surviving in company of BCG

    • G. Mathé

    Editorial Pages: 3 - 5